Denis C L, Draper M P, Liu H Y, Malvar T, Vallari R C, Cook W J
Department of Biochemistry and Molecular Biology, University of New Hampshire, Durham 03824.
Genetics. 1994 Dec;138(4):1005-13. doi: 10.1093/genetics/138.4.1005.
The CCR4 protein is specifically required for the increased transcription at the ADH2 locus resulting from mutations in the SPT10 (CRE1) and SPT6 (CRE2) genes and is also required for the expression of ADH2 and other genes under non-fermentative growth conditions. The mechanism by which mutations in CCR4 suppress defects in SPT10 and SPT6 was examined. The SPT10 and SPT6 genes were shown not to control CCR4 mRNA or protein expression nor did SPT10 and SPT6 proteins co-immuneprecipitate with CCR4. CCR4 association with two other proteins, 195 and 185 kDa in size, was unaffected by either spt10 or spt6 mutations. Also, the ability of CCR4 to activate transcription when fused to the LexA DNA binding domain was not specifically enhanced by defects in either SPT10 or SPT6. These results suggest that SPT10 and SPT6, in negatively regulating transcription at ADH2, act through a factor that requires CCR4 function, but do not regulate CCR4 expression, control its activity, physically interact with it, or affect its binding to other factors. The relationship of CCR4 to the group of general transcription factors, SNF2, SNF5, SNF6 and SWI1 and SWI3, which comprise a multisubunit complex required for ADH2 and other genes' expression, was also examined. CCR4 protein expression was not controlled by these factors nor did they co-immuneprecipitate or associate with CCR4. In addition, a ccr4 mutation had little effect on an ADH2 promoter alteration in contrast to the large effects displayed by mutations in SNF2 and SNF5. These data suggest that CCR4 acts by a separate mechanism from that used by the SNF/SWI general transcription factors in affecting gene expression.
CCR4蛋白是SPT10(CRE1)和SPT6(CRE2)基因突变导致ADH2基因座转录增加所特别需要的,并且在非发酵生长条件下ADH2和其他基因的表达也需要它。研究了CCR4突变抑制SPT10和SPT6缺陷的机制。结果表明,SPT10和SPT6基因不控制CCR4 mRNA或蛋白质表达,SPT10和SPT6蛋白也不与CCR4共免疫沉淀。CCR4与另外两种大小分别为195 kDa和185 kDa的蛋白质的结合不受spt10或spt6突变的影响。此外,当与LexA DNA结合结构域融合时,CCR4激活转录的能力不会因SPT10或SPT6的缺陷而特别增强。这些结果表明,SPT10和SPT6在负调控ADH2转录时通过一种需要CCR4功能的因子起作用,但不调控CCR4表达、控制其活性、与它发生物理相互作用或影响其与其他因子的结合。还研究了CCR4与一组通用转录因子SNF2、SNF5、SNF6以及SWI1和SWI3的关系,这些因子构成了ADH2和其他基因表达所需的多亚基复合物。CCR4蛋白表达不受这些因子控制,它们也不与CCR4共免疫沉淀或结合。此外,与SNF2和SNF5突变所显示的大影响相反,ccr4突变对ADH2启动子改变的影响很小。这些数据表明,CCR4在影响基因表达时通过与SNF/SWI通用转录因子不同的机制起作用。